The Journal of Experimental Medicine
R&D Systems
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article
Right arrow Alert me to new content in the JEM
Citing Articles
Right arrow Citing Articles via CrossRef

Index of Online Supplemental Material for
J. Exp. Med. 10.1084/jem.20071094
Zaba et al.

• Figure S1 IL-1β, IL-6, and IL-8 are rapidly down-modulated with etanercept treatment.

• Figure S2 In vitro–derived DCs matured with etanercept produce less IL-23 and are less immunostimulatory than control DCs.

• Figure S3 Nonresponder data.





This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article
Right arrow Alert me to new content in the JEM
Citing Articles
Right arrow Citing Articles via CrossRef

  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS